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    INTRODUCTION  
  In cardiac muscle, the type-2 ryanodine receptor (RyR2) 
channel plays a central role in excitation  –  contraction 
coupling. The cardiac action potential triggers a small 
Ca 
2+   infl  ux through the L-type Ca 
2+   channel and this Ca 
2+   
infl  ux activates nearby RyR2 channels, initiating Ca 
2+   
release from the SR. This process is known as Ca 
2+  -induced 
Ca 
2+   release (CICR). How CICR is controlled in cells re-
mains an open question. 
  The open probability (Po) of single RyR2 channels is 
sensitive to changes in the intra-SR Ca 
2+   level ( Lukyanenko 
et al., 1996  ;   Gyorke and Gyorke, 1998  ). A drop in local 
intra-SR Ca 
2+   has been proposed to help   “  turn off  ”   
RyR2-mediated SR Ca 
2+   release, stabilizing CICR in car-
diac muscle (  Lukyanenko et al., 2001  ;   Terentyev et al., 
2002  ;   Gyorke et al., 2004  ). The mechanism of this RyR2 
intra-SR (luminal) Ca 
2+   regulation, however, is not well 
understood. It may involve a Ca 
2+   binding site(s) on the 
luminal surface of the RyR2 channel itself and/or Ca 
2+   
interactions with RyR2-associated intra-SR regulatory 
proteins like calsequestrin (CSQ). Calsequestrin is a low 
affi   nity, high capacity intra-SR Ca 
2+  -binding protein 
(  Fliegel et al., 1987  ;   Scott et al., 1988  ;   Choi and Clegg, 
1990  ;   Fujii et al., 1990  ;   Arai et al., 1991  ;   Treves et al., 
1992  ). Cardiac muscle contains only one CSQ isoform 
(CSQ2;   Lahat et al., 2001  ) whereas skeletal muscle con-
tains two (CSQ1 and CSQ2;   Paolini et al., 2007  , and ref-
erences therein). The two CSQ isoforms are quite similar 
but the C terminus of CSQ2 possesses variable lengths 
of acidic residues and two consensus phosphorylation 
sites (  Yano and Zarain-Herzberg, 1994  ). Several Ca 
2+   ions 
(20  –  80) bind to CSQ with a K  D   around 2 mM (  di Barletta 
et al., 2006  ). Calcium binding induces a signifi  cant con-
formational change in the CSQ protein (  Slupsky et al., 
1987  ;   Mitchell et al., 1988  ) prerequisite of the CSQ oligo-
merization process (  Park et al., 2003  ). The RyR and CSQ 
are closely associated and this association is thought to 
involve other integral SR proteins, triadin and junctin 
(  Gyorke et al., 2004  ). It is now commonly believed that 
CSQ2 acts not only as a local intra-SR Ca 
2+   buffer but as 
a Ca 
2+  -dependent regulator of RyR2 channel function 
(  Bers, 2004  ;   Terentyev et al., 2007  ). 
  The objective of this paper is to explore mechanisms 
of luminal Ca 
2+   regulation of single RyR2 channels. An 
effective luminal RyR2 Ca 
2+   regulation mechanism must 
fi  rst be able to distinguish between luminal Ca 
2+   and 
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The luminal Ca
2+ regulation of cardiac ryanodine receptor (RyR2) was explored at the single channel level. The 
luminal Ca
2+ and Mg
2+ sensitivity of single CSQ2-stripped and CSQ2-associated RyR2 channels was defi  ned. Action 
of wild-type CSQ2 and of two mutant CSQ2s (R33Q and L167H) was also compared. Two luminal Ca
2+ regulatory 
mechanism(s) were identifi  ed. One is a RyR2-resident mechanism that is CSQ2 independent and does not distin-
guish between luminal Ca
2+ and Mg
2+. This mechanism modulates the maximal effi  cacy of cytosolic Ca
2+ activation. 
The second luminal Ca
2+ regulatory mechanism is CSQ2 dependent and distinguishes between luminal Ca
2+ and 
Mg
2+. It does not depend on CSQ2 oligomerization or CSQ2 monomer Ca
2+ binding affi  nity. The key Ca
2+-sensitive 
step in this mechanism may be the Ca
2+-dependent CSQ2 interaction with triadin. The CSQ2-dependent mecha-
nism alters the cytosolic Ca
2+ sensitivity of the channel. The R33Q CSQ2 mutant can participate in luminal RyR2 
Ca
2+ regulation but less effectively than wild-type (WT) CSQ2. CSQ2-L167H does not participate in luminal RyR2 
Ca
2+ regulation. The disparate actions of these two catecholaminergic polymorphic ventricular tachycardia 
(CPVT)–linked mutants implies that either alteration or elimination of CSQ2-dependent luminal RyR2 regulation 
can generate the CPVT phenotype. We propose that the RyR2-resident, CSQ2-independent luminal Ca
2+ mecha-
nism may assure that all channels respond robustly to large (>5 μM) local cytosolic Ca
2+ stimuli, whereas the CSQ2-
dependent mechanism may help close RyR2 channels after luminal Ca
2+ falls below 0.5 mM.
Abbreviations used in this paper: BAPTA, 1,2-bis(2-aminophenoxy)ethane-
  N  ,  N  ,  N  ’,  N  ’-tetraacetic acid; CICR, Ca 
2+ -induced Ca 
2+  release; CPVT, 
catecholaminergic polymorphic ventricular tachycardia; RyR2, type-2 
ryanodine receptor; WT, wild-type.326   Luminal Ca 
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et al. (2006)  . Purifi  cation was done by phenyl-sepharose purifi  ca-
tion either in column or in batch. Proteins were quantifi  ed ac-
cording to standard procedures (  Lowry et al., 1951  ). Native CSQ2 
protein was also isolated from adult rat hearts using established 
procedures (  Kobayashi et al., 2000  ). 
  In Vitro Binding Assay Using a T7-Afﬁ  nity Column 
  Vesicles of the heavy SR fraction, prepared from rabbit hearts pre-
viously described (  Saito et al., 1984  ), were solubilized in a buffer 
containing 3% CHAPS, 1 M NaCl, 20 mM Tris-HCl, pH 7.5, 1 mM 
DTT, and protease inhibitors. Solubilized membranes were cen-
trifuged at 105,000   g   in a Beckman Airfuge for 1 h. The super-
natant was precleared with T7-affi  nity beads for 2 h at 4  °  C to 
eliminate nonspecifi  c binding and then incubated with the T7-
CSQ2 affi  nity beads in 0.3% CHAPS, 20 mM Tris-HCl pH 7.5, 0.15 M 
NaCl, 1 mM DTT for 20 h at 4  °  C in the presence of either 1 mM 
EGTA or 1 mM CaCl  2  . Bound proteins were eluted by boiling in 
the SDS sample buffer and subjected to SDS-PAGE (  Laemmli, 
1970  ) in 10% polyacrylamide gels. After electrophoretic separa-
tion, proteins were either stained with Coomassie staining or 
transferred onto nitrocellulose membranes. Western blots with 
the Sh33 anti-Triadin antibody (  Guo et al., 1996  ) were performed 
using polyclonal antibodies (gift from K.P. Campbell, The Univer-
sity of Iowa, Iowa City, IA). Densitometric analysis was performed 
with Image for Windows software (version Beta 4.0.2; Scion). 
  Turbidity Measurements 
  Experiments were performed in a double-beam Model Lambda-2 
spectrophotometer (Perkin-Elmer), with a 1-cm path length quartz 
cell at room temperature. Turbidity measurements of CSQ2-WT, 
CSQ2-R33Q, and CSQ2-L167H (100   μ  g/ml protein) were per-
formed by adding 1  –  2-  μ  l aliquots of concentrated CaCl  2   solution 
(0.1  –  1 M) in 20 mM MOPS, pH 7.2, 100 mM CsCl. At each addi-
tion, protein samples were stirred and equilibrated for 2 min be-
fore measuring absorbance at 350 nm. Data were corrected for 
sample dilution and expressed as absorbance at 350 nm. 
  Sarcoplasmic Reticulum Preparation 
  Sarcoplasmic reticulum microsomes were prepared from rat 
heart, according to published methods (  Chamberlain et al., 1984  ). 
In brief, ventricles were cut into 5  –  10-mm cubes before 30  –  32-g 
portions were homogenized in 5 volumes (vol/wt) of sucrose, 0.5 
mM dithiothreitol, 3 mM NaN3, and 10 mM imidazole-HCl, pH 
6.9. The homogenate was centrifuged 15 min at 5,000 rpm (3,800   g  ). 
The supernatant was fi  ltered and centrifuged again at 13,500 rpm 
for 15 min (27,900   g  ). After fi  ltration through cheesecloth, the 
supernatant was centrifuged for 2 h at 32,000 rpm (119,200   g  ). 
The pellet was resuspended and samples quick frozen in liquid 
nitrogen. Stored aliquots were quickly defrosted, kept on ice, and 
used within 5 h. 
  Single-Channel Recording 
  Planar lipid bilayers were formed from a 5:3:2 mixture of bovine 
brain phosphatidylethanolamine, phosphatidylserine, and phos-
phatidylcholine (50 mg/ml in decane) across a 100-  μ  m hole in a 
12-micron-thick Tefl  on partition. This hole separated two aque-
ous compartments. One compartment (trans) was fi  lled  with 
HEPES-Ca 
2+   (10 mM Ca 
2+  , pH 7.4) and virtually grounded through 
a patch-clamp amplifi  er. The trans compartment always contains 
the luminal side of the RyR2 channel (  Tu et al., 1994  ). The other 
compartment (cis) was fi  lled with HEPES-TRIS solution (114 mM 
TRIS, pH 7.4). Subsequently, 500  –  1000 mM Cs-methanesulfo-
nate, 2 mM CaCl  2  , and then 5  –  15   μ  g of the cardiac SR microsome 
preparation were added to the cytosolic compartment while stir-
ring. Once channel activity was observed, the solutions in both 
compartments were exchanged at a rate of 4 ml/min (for 5 min) to 
establish the desired test conditions. Unless otherwise specifi  ed, 
Mg 
2+   (because luminal Mg 
2+   is likely always present at 
millimolar levels). Second, it should operate between 
0.2 and 1 mM, the putative range over which local intra-
SR Ca 
2+   likely varies in cells. Third, it should substan-
tially reduce RyR2 open probability (Po) as luminal Ca 
2+   
decreases if its role is to help terminate CICR. The 
CSQ2-dependent luminal RyR2 Ca 
2+   regulation mecha-
nism delineated here appears to meet these criteria. 
  Molecular insight into the CSQ2-dependent regula-
tory mechanism was attained not only using native and 
recombinant CSQ2 but also using two CSQ2 mutants 
linked to recessive forms of catecholaminergic polymor-
phic ventricular tachycardia (CPVT). CPVT is a familial 
arrhythmogenic disorder characterized by adrenergi-
cally mediated polymorphic ventricular tachyarrhythmias, 
leading to syncope and sudden cardiac death in individ-
uals with otherwise structurally normal hearts. The tachyar-
rhythmia is typically triggered by physical exercise or 
emotional stress (  Leenhardt et al., 1995  ). A recessive 
form of CPVT is associated with homozygous mutations 
in the gene encoding CSQ2 (  Kontula et al., 2005  ). Two of 
these CPVT-linked CSQ2 point mutations are R33Q 
(  Terentyev et al., 2006  ) and L167H (  di Barletta et al., 
2006  ).   Terentyev et al. (2006)   showed that the R33Q 
mutant abnormally regulated single RyR2 channels and 
demonstrated that R33Q overexpression (on top of the 
endogenous CSQ2 already present) promoted abnor-
mal spontaneous diastolic Ca 
2+   release events (waves and 
sparks) in cardiomyocytes. Using the same approach, 
  di Barletta et al. (2006)   found that overexpression of 
the L167H mutant did not substantially alter Ca 
2+   re-
lease compared with control myocytes (i.e., it was as if 
no CSQ2 overexpression had occurred). The action of 
L167H on single RyR2 channels was not tested. 
  Here, we show that the R33Q mutant reduced RyR2 
Po at submillimolar luminal Ca 
2+   concentrations but less 
effectively than wild-type (WT) CSQ2. Whereas, the ac-
tion of the L167H mutant was as if no CSQ2 were pre-
sent. Our results also indicate that Ca 
2+  -dependent 
signaling between CSQ2 and triadin is important to 
RyR2 luminal Ca 
2+   regulation. 
  MATERIALS AND METHODS  
  Chemicals and Drugs 
  BAPTA (1,2-bis(2-aminophenoxy)ethane-  N  ,  N  ,  N    ’  ,  N    ’  -tetraacetic 
acid), 5,5   -Dibromo-BAPTA (1,2-bis(2-amino-5-bromophenoxy)ethane-
  N  ,  N  ,  N    ’  ,  N    ’  - tetraacetic acid), Ca(OH)  2  , CsCl, and HEPES were ob-
tained from Fluka. CaCl  2   standard for calibration was from World 
Precision Instruments Inc. Phospholipids were obtained from 
Avanti Polar Lipids and decane from Sigma-Aldrich. All other 
drugs and chemicals were either from Fluka or Sigma-Aldrich and 
were reagent grade. 
  Production and Puriﬁ  cation of Recombinant Calsequestrin 
  CSQ2 constructs were generated as previously described (  di 
Barletta et al., 2006  ;   Terentyev et al., 2006  ). Expression and induc-
tion of recombinant CSQ2 proteins were according to   Terentyev     Qin et al.  327
Ca 
2+   level was elevated from 10 to 1000   μ  M. The Po de-
creased at higher Ca 
2+   levels. These luminal Ca 
2+  -depen-
dent Po changes in control channels were reversible. 
  As described in methods, exposure of the luminal 
side of the channel to a   >  10-min 10 mM Ca 
2+   prewash 
dissociates (strips) CSQ2 from the channel. The control 
channel data shown   Fig. 1 B   (fi  lled circles) were never 
subjected to this prewash. The control channel data, 
however, includes Po data collected at 10 mM luminal 
Ca 
2+   that is consistent with CSQ2 still being associated 
with the channel. This is possible because these control 
the holding potential was always constant at 0 mV and all record-
ings were made at room temperature (20  –  22  °  C). 
  In many experiments, luminal Ca 
2+   or Mg 
2+   was varied from 
0.01 to 10 mM. The luminal solution also contained 100 mM Cs 
+   
to assure ample charge carrier was ever present. Consequently, 
the net unit current (always in the lumen-to-cytosol direction) 
was carried by a mixture of ions (Cs 
+   and either Ca 
2+   or Mg 
2+  ). 
The fraction of the net current carried by the divalent varied with 
the ionic conditions present. A published RyR permeation model 
was used to estimated the unidirectional Ca 
2+   current from net 
current (  Gillespie et al., 2005  ;   Xu et al., 2006  ). In our experimen-
tal conditions, this Ca 
2+   current was   <  0.01,     0.2, or     1 pA when 
0.01, 1, or 10 mM luminal Ca 
2+   was present, respectively. 
  Single-channel currents were digitized at 10 kHz and fi  ltered at 
1  –  2 kHz using an A/D converter and amplifi  er (Axon CMS 
Molecular Devices). Acquired data were analyzed using pClamp 
(Axon CMS Molecular Devices). Open probability determina-
tions were made from recordings lasting 120  –  240 s. 
  Single-Channel CSQ2 Stripping and CSQ2 Replacement 
  Single RyR2 channel were reconstituted in planar lipid bilayer 
from native SR vesicles as described above. After their incorpor-
ation into the bilayer, the luminal side of some channels were 
subjected to a   >  10 min 10 mM Ca 
2+   solution prewash to promote 
dissociation of CSQ2 (if present) from the channel. This process 
is analogous to that applied by   Gyorke et al. (2004)   and   Beard 
et al. (2005)  . We refer to channels subjected to this procedure as 
CSQ2 stripped channels. In some cases, CSQ2 (WT or mutant) 
protein was added to the luminal side at 5   μ  g/ml of previously 
CSQ2 stripped RyR2 channels. The added CSQ2 can then associ-
ate with the channels and we call these CSQ2-replaced channels. 
  Note that the cytosolic side of the RyR2 channel was not sub-
jected to the high salt wash and thus this treatment could not 
have   “  salted off  ”   cytosolic RyR2  –  protein partners like FKBP. Since 
the high salt wash was done at the single-channel level (not at the 
SR vesicle level), it was not possible to biochemically confi  rm 
CSQ2 association/dissociation before/after the salt wash. 
  RESULTS  
  The channels tested were pharmacologically identifi  ed 
as RyR channels consistent with our previous studies 
(  Mejia-Alvarez et al., 1999  ;   Kettlun et al., 2003  ). They 
were inhibited by 2 mM cytosolic Mg 
2+   or 10 mM cyto-
solic Ca 
2+  . They were activated by either 1   μ  M cytosolic 
Ca 
2+  , 5 mM ATP, or 10 mM caffeine. Their gating/con-
ductance was characteristically modifi  ed by 10   μ  M ry-
anodine and their permeation characteristics consistent 
with being RyR2 channels (  Fill and Copello, 2002  ). 
    Fig. 1 A   (left) shows sample single RyR2 channel re-
cordings of a control channel at various luminal Ca 
2+   
levels. Control channels are those that were never ex-
posed to high luminal Ca 
2+   level and thus could have 
endogenous CSQ associated with them.     Fig. 1 A   (right) 
shows the luminal Mg 
2+   sensitivity of a CSQ2-associated 
channel.   Fig. 1 B   shows summary open probability (Po) 
data collected from experiments on several different 
channels. The activity of CSQ2-associated channels 
showed no luminal Mg 
2+   sensitivity (  Fig. 1 B  , open cir-
cles). Control channels responded to luminal Ca 
2+   as il-
lustrated by the fi  lled circles (  Fig. 1 B  ). The Po of control 
channels increased from     0.02 to 0.2 when the luminal 
  Figure 1.     Luminal Ca 
2+   and Mg 
2+   sensitivity of RyR2 channels. 
Channels were incorporated into bilayers by fusing heavy native 
SR microsomes. Cytosolic free Ca 
2+   concentration was constant 
(1   μ  M). The luminal Ca 
2+   or Mg 
2+   concentration was titrated from 
10   μ  M to 10 mM. Holding potential was 0 mV. The luminal solu-
tion contained 100 mM Cs 
+   and net unit current was always in the 
lumen-to-cytosolic direction. (A) Example single channel record-
ings with zero current level marked. Recordings at left are from 
a control channel that was never exposed to the CSQ2 stripping 
process with no added CSQ2 in the luminal bathing solution. 
Recordings at right are from a channel that was fi  rst CSQ2 stripped 
before 0.5   μ  g/ml CSQ2-WT was added to the luminal solution. 
(B) Summary Po results (mean   ±   SEM) where the fi  lled circles 
represent the Ca 
2+   sensitivity of 11 different control channels 
and the open circles represent the Mg 
2+   sensitivity of 10 different 
channels. The X-marked circles represent data collected from 
six different CSQ2-associated control channels in the presence of 
3 mM cytosolic diBromoBAPTA.     328   Luminal Ca 
2+   Regulation 
corresponding individual determinations (open sym-
bols) for each situation are plotted. The normality 
of the distributions about their means was tested using 
the Anderson-Darling and Shapiro-Wilk normality tests. 
These tests indicate a distribution is statistically differ-
ent than normal if the statistic P is less than 0.05. These 
tests indicated that the control channel data popula-
tion was the only one that was statistically different 
than normal (  Fig. 3  , bottom). This supports the con-
tention that the control channel population contains 
two classes of channels (i.e., those with and without 
CSQ2 attached). 
channel recordings at 10 mM were relatively short (    2 
min). In our hands, CSQ2 dissociation required at least 
a 4-min exposure to a 10 mM Ca 
2+   solution. Dissociation 
of CSQ2 from a control channel was considered to be 
coincident with sustained Po reduction. Attempts to 
better defi  ne this phenomenon were unsuccessful (due 
to variability and a relatively low n). 
  It is known that large Ca 
2+   currents in the lumen-to-
cytosol direction can change local cytosolic Ca 
2+   levels 
suffi  ciently to alter the Po of single RyR2 channels (  Xu 
and Meissner, 1998  ). This is called feed-through Ca 
2+   
modulation. To assess if feed-through Ca 
2+   modulation 
infl  uences our observations, luminal Ca 
2+   sensitivity 
of control channels was also measured in the presence 
of 3 mM cytosolic diBromoBAPTA (  Fig. 1 B  , X-marked 
fi  lled circles). With this fast Ca 
2+   buffer present, the lu-
minal Ca 
2+   sensitivity of CSQ2-associated channels be-
came more sigmoidal with an EC  50   of 687   ±   37   μ  M. This 
implies that Ca 
2+   passing through the channel when 
high luminal Ca 
2+   levels (5 and 10 mM) are present 
feeds back and inhibits the channel, generating the ob-
served   “  bell-shaped  ”   luminal Ca 
2+   sensitivity. This is con-
sistent with the large fraction of the net current being 
carried by Ca 
2+   when 5 and 10 mM Ca 
2+   are present (see 
Materials and methods). 
  Example single channel recordings illustrating the 
luminal Ca sensitivity of a CSQ2 stripped channel are 
shown in   Fig. 2 A   (left).   Summary Po results from sev-
eral CSQ stripped channels are shown in   Fig. 2 B   (open 
diamonds). The Po of stripped channels did not change 
over the tested luminal Ca 
2+   range. The lost luminal 
Ca 
2+   sensitivity following the stripping procedure sug-
gests the luminal Ca 
2+   sensitivity of control channels 
(see   Fig. 1 B  ) was CSQ2 dependent. This was tested 
by adding recombinant purifi  ed CSQ2 (0.5   μ  g/ml) to 
the luminal side of previously CSQ2-stripped channels. 
Sample recordings from CSQ2-replaced channels are 
shown in   Fig. 2 A   (right). The average luminal Ca 
2+   sen-
sitivity of several CSQ2-replaced channels is shown in 
  Fig. 2 B   (fi  lled circles). The dotted line in   Fig. 2 B   rep-
resents the control channel data presented in   Fig. 1 B  . 
The CSQ2-replaced and control channels have analo-
gous luminal Ca 
2+   sensitivities. However, there is a clear 
difference in the peak Po reached at 1000   μ  M luminal 
Ca 
2+  . The reason for this may be that not all of the con-
trol channels had CSQ2 associated with them and this 
possibility is examined further below. 
  The results shown in   Fig. 3   were collected in the pres-
ence of 1   μ  M cytosolic Ca 
2+   and 1 mM luminal Ca 
2+   in 
three different experimental situations.   The fi  rst situa-
tion is labeled control where channels had never been 
exposed to the CSQ2 stripping procedure. The second 
is stripped where channels were exposed to the strip-
ping procedure. The third is replaced where CSQ2 
(0.5   μ  g/ml) was added back to previously stripped 
channels. In   Fig. 3   (top), the mean (fi  lled symbols) and 
  Figure 2.     Luminal Ca 
2+   of CSQ2-stripped and CSQ2-added RyR2 
channels. The CSQ2-added channels here refer to channels that 
were fi  rst CSQ2 stripped before 0.5   μ  g/ml CSQ2-WT was added 
to the luminal solution. Cytosolic free Ca 
2+   concentration was con-
stant (1   μ  M). The luminal Ca 
2+   or Mg 
2+   concentration was titrated 
from 10   μ  M to 10 mM. Holding potential was 0 mV. The luminal 
solution contained 100 mM Cs 
+   and net unit current was always 
in the lumen-to-cytosolic direction. (A) Example single channel 
recordings from a CSQ2-stripped channel (left) and a CSQ2-
added channel (right). Zero current levels are marked. Bar, 2 pA.
(B) Summary Po results. Luminal Ca 
2+   sensitivity of the CSQ2-added 
data (black circles) was collected from 14 different channels. 
Luminal Ca 
2+   sensitivity of the CSQ2-stripped data (open diamonds) 
was collected from six different channels. Dotted line represents 
control Po result presented in   Fig. 1 B  .         Qin et al.  329
This is more than 10-fold higher than the measured 
EC  50   of cytosolic RyR2 Ca 
2+   activation and thus assures 
there is no (or very little) feed-through Ca 
2+   activation 
here. The Po of these CSQ2-free channels was     0.4 
when luminal Ca 
2+   was 10   μ  M. It rose to     0.8 when lu-
minal Ca 
2+   was increased to 10 mM (  Fig. 4 B  , open dia-
monds). The EC  50   of this CSQ2-independent luminal 
Ca 
2+   activation was 379   ±   247   μ  M. Interestingly, very 
similar results were obtained if Mg 
2+  , instead of Ca 
2+  , 
was applied to the luminal side of the channel (  Fig. 4 B  , 
open squares). The EC  50   of this luminal Mg 
2+   activation 
was 972   ±   208   μ  M. No signifi  cant differences in Po at 
any luminal divalent concentrations were found. This 
indicates that the CSQ2-independent mechanism does 
not discriminate well between luminal Ca 
2+   and Mg 
2+  . 
  Several mutants of CSQ2 are linked to the tachyar-
rhythmic disorder CPVT. How two of these CSQ2 mu-
tants (R33Q and L167H) regulate single RyR2 channels 
is shown in   Fig. 5  .   Single RyR2 channels were incorpo-
rated into the bilayer and then stripped of any endog-
enous CSQ2 present. With 1   μ  M cytosolic Ca 
2+   always 
present, the luminal Ca 
2+   concentration was titrated 
in the presence of either the R33Q or L167H mutant 
(0.5  μ  g/ml). Sample single channel recordings are shown 
  To this point, RyR2 luminal Ca 
2+   sensitivity has been 
defi  ned in the presence of a constant 1   μ  M cytosolic 
bath Ca 
2+   concentration.   Fig. 4   A shows how CSQ2 af-
fects RyR2 cytosolic Ca 
2+   sensitivity at a constant luminal 
Ca 
2+   concentration (1 mM).   The cytosolic Ca 
2+   sensitiv-
ity of CSQ2-stripped (  Fig. 4 A  , open diamonds) and 
CSQ2-replaced channels (  Fig. 4 A  , fi  lled circles) is com-
pared. The EC  50   of cytosolic Ca 
2+   activation was 2.01   ±   
0.34   μ  M (maximum Po     0.6) when no CSQ2 was asso-
ciated with the channel. It was 1.04   ±   0.17   μ  M (maxi-
mum Po     0.8) when CSQ2 was present. An unpaired 
  T   test was used to determine if mean Po  ’  s of the CSQ2-
replaced and stripped channels at each of the different 
cytosolic Ca 
2+   levels were statistical different. The Po was 
signifi  cantly different at all cytosolic Ca 
2+   levels   >  0.5   μ  M. 
Note that the lumen-to-cytosolic Ca 
2+   fl  ux was essentially 
constant in these experiments because luminal Ca 
2+   was 
always 1 mM. Thus, this CSQ2-dependent change in cy-
tosolic RyR2 Ca 
2+   sensitivity was not the result of feed-
through Ca 
2+   modulation. 
  The dashed line in   Fig. 4   A summarizes the cytosolic 
Ca 
2+   sensitivity of CSQ2-stripped channels in the pres-
ence of 10 mM luminal Ca 
2+  , instead of 1 mM (  Fig. 4 A  , 
open diamonds). These data show that luminal Ca 
2+   (in 
absence of CSQ2) changes the maximal Po level, not 
the cytosolic Ca 
2+   affi  nity, of the channel. This is a form 
of CSQ2-independent luminal RyR2 Ca 
2+   regulation. 
  Fig. 4 B   further explores this CSQ2-independent regu-
lation. The luminal divalent cation titrations shown 
(  Fig. 4 B  ) were done with 100   μ  M cytosolic Ca 
2+   present. 
  Figure 3.     Normality testing. Data collected in the presence of 
1   μ  M cytosolic Ca 
2+   and 1 mM lumenal Ca 
2+   in three different 
experimental situations. Control represents channels that were 
not subjected to the CSQ2 stripping process. Stripped represents 
channels that underwent the stripping process. Replaced repre-
sents stripped channels after CSQ2 (0.5   μ  g/ml) was added to the 
luminal bath. Open symbols are individual determinations. Filled 
symbols are means (  ±  SEM). Outcome of the Anderson-Darling 
and Shapiro-Wilk normality tests are shown at the bottom.     
  Figure 4.     CSQ2 shifted the cytosolic Ca 
2+   sensitivity of single 
RyR2 channels. Holding potential was 0 mV and the luminal solu-
tion contained 100 mM Cs 
+  . (A) Summary Po results from CSQ2-
stripped (open circles;   n   = 8) and CSQ2-replaced (fi  lled  circles; 
  n   = 6) channels. The CSQ2-replaced channels were associated 
with CSQ2-WT (0.5   μ  g/ml in luminal chamber). Luminal free 
Ca 
2+   concentration was 1 mM and cytosolic Ca 
2+   was titrated from 
0.1 to 100   μ  M. The curve fi  t to the fi  lled circles has an EC  50   of 1.04   ±   
0.17   μ  M and a 3.4 Hill coeffi  cient. The curve fi  t to the CSQ2-
stripped data has an EC  50   of 2.01   ±   0.34   μ  M and a 2.6 Hill coeffi  -
cient. An unpaired   t   test was used to determine if the Po between 
CSQ2-replaced and stripped channels at each Ca 
2+   concentration 
was statistically different (**, P   <   0.01; *, P   <   0.05). Dotted curve 
represents the cytosolic Ca 
2+   sensitivity of CSQ2-stripped chan-
nels when 10 mM luminal Ca 
2+   was present. (B) Luminal Ca 
2+   and 
Mg 
2+   sensitivity of CSQ2-stripped channels. These stripped chan-
nels were maximally activated by high cytosolic Ca 
2+   (100   μ  M) and 
then luminal Ca 
2+   (open diamond;   n   = 13) or Mg 
2+   (open square; 
  n   = 16) was varied. The curve fi  t to the Ca 
2+   data has an EC  50   of 
379   ±   247   μ  M and a 0.70 Hill coeffi  cient. The curve fi  t to the Mg 
2+   
data has an EC  50   of 972   ±   208   μ  M and a 0.77 Hill coeffi  cient.     330   Luminal Ca 
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not statistically different (  t   test P   >   0.1) between the 
CSQ2-R33Q and CSQ2-WT datasets. In the presence of 
the L167H mutant (  Fig. 5 B  , fi  lled inverted triangles), 
the Po did not change as the luminal Ca 
2+   concentra-
tion varied. Indeed, the Po  ’  s at 10   μ  M, 1 mM, and 10 mM 
luminal Ca 
2+   were not statistically different (  t   test P   >   
0.1) when these data were compared with the stripped 
(CSQ2-free) channel data. 
  The differences in CSQ2-dependent RyR2 function 
(  Fig. 5 B  ) could conceivably arise due to mutant vs. WT-
dependent differences in CSQ2 oligomerization and/
or the CSQ2  –  RyR2 interaction. Light scattering was used 
to measure the Ca 
2+   dependence of CSQ2 oligomeriza-
tion in conditions (100 mM CsCl) similar to those used 
for bilayer experiments (  Fig. 6 A  ).   Increased light scat-
tering here refl  ects more CSQ2 oligomerization. The 
CSQ2-WT and CSQ2-R33Q proteins oligomerized at 
Ca 
2+   levels   >  3 mM and this oligomerization had similar 
Ca 
2+   dependency. Virtually no oligomerization of the 
CSQ2-L167H protein was observed over the Ca 
2+   con-
centration range tested. 
  The CSQ2  –  RyR2 functional interaction most likely in-
volves the Triadin protein (  Gyorke et al., 2004  ;   Terentyev 
et al., 2007  ). In cardiac muscle, there is one isoform of 
in   Fig. 5 A  . Single RyR2 channels associated with the 
R33Q mutant were sensitive to luminal Ca 
2+  . Channels 
associated with the L167H mutant were not.   Fig. 5 B   
shows summary results collected from many different 
channels. The dashed line represents the luminal Ca 
2+   
sensitivity of channels associated with WT CSQ2 (from 
  Fig. 2 B  ). Channels associated with the R33Q mutant 
(fi  lled triangles) had signifi  cantly higher Po (  t   test P   <   
0.05) at luminal   ≤  250   μ  M compared with those chan-
nels associated with WT CSQ2. However, their Po was 
similar to channels associated with WT CSQ2 at 1 mM 
luminal Ca 
2+  . The Po at 5 and 10 mM luminal Ca 
2+   were 
  Figure 5.    Luminal Ca 
2+   regulation of RyR2 channels by the CSQ2-
R33Q and CSQ2-L167H mutants. Mutant CSQ2 (0.5   μ  g/ml) was 
added to the luminal side of previously CSQ2-stripped channels. 
Cytosolic free Ca 
2+   concentration was 1   μ  M and luminal Ca 
2+   was 
titrated from 10   μ  M to 10 mM. Holding potential was 0 mV and 
the luminal solution contained 100 mM Cs 
+  . (A) Example chan-
nel recordings with CSQ2-R33Q (left) or CSQ2-L167H (right) 
present are shown (zero current level marked). (B) Summary 
Po results. The CSQ2-R33Q data (triangle) was collected on eight 
different channels. The CSQ2-L167H data (inverted triangles) 
was collected on eight different channels as well. Dotted line rep-
resents CSQ2-WT result presented in   Fig. 2 B  .     
  Figure 6.     Ca 
2+  -dependent CSQ2 oligomerization and CSQ2  –  tria-
din interaction. (A) The Ca 
2+   sensitivity of light (350 nm) scat-
tering of CSQ2-WT (fi  lled circles), CSQ2-R33Q (triangles), and 
CSQ2-L167H (inverted triangles) proteins in presence of 100 mM 
CsCl. Samples were stirred for 2 min before measurement. The 
curve fi  t to the CSQ2-WT data has an EC  50   of 18.1   ±   5.23 mM and 
a 2.1 Hill coeffi  cient. The curve fi  t to the CSQ2-R33Q data has 
an EC  50   of 16.4   ±   1.18 mM and a 3.0 Hill coeffi  cient. Both curves 
were fi  t with V  MAX   arbitrarily fi  xed at 0.6. (B) At left, top panel 
(i) depicts the Coomassie blue  –  stained SDS-PAGE of purifi  ed, 
recombinant CSQ2-WT (arrow, MW of     52,000). Bottom panel 
(i) depicts the Western blot with anti-triadin antibodies, revealing 
two bands having MW of     45,000 (glycosylated form) and 40,000 
(unglycosylated form), respectively. At right (ii), the Ca 
2+   sensitiv-
ity of the interaction of glycosylated and unglycosylated triadin 
with CSQ2-WT, CSQ2-R33Q, and CSQ2-L167H was measured with 
either very low Ca 
2+   (1 mM EGTA) or 1 mM free Ca 
2+   present, and 
data are shown as means   ±   SEM (  n   = 5). Filled bars represent 
glycosylated triadin, open bars represent unglycosylated triadin. 
Asterisk indicates P   <   0.05 using an unpaired Student  ’  s   t   test.         Qin et al.  331
is a CSQ2-dependent mechanism that helps to stabilize 
RyR2-mediated CICR in cardiac muscle. 
  Here, we explore this view using no cytosolic activa-
tors (such as sulmazole, caffeine, or ATP) and report ab-
solute Po (not normalized or relative Po) values. 
  Luminal RyR2 Ca 
2+   Regulation without CSQ2 Present 
  We showed that CSQ2-free RyR2 channels, activated by 
1   μ  M cytosolic Ca 
2+  , were not sensitive to luminal Ca 
2+   
(  Fig. 2 B  , open diamonds). This may be what some pre-
vious single channel studies observed and may explain 
why many previous investigators were compelled to ap-
ply cytosolic channel activators. Many of the selected ac-
tivators are known to make the channel hypersensitive 
to cytosolic Ca 
2+   (  Fill and Copello, 2002  ), enhancing 
the prospect of feed-through Ca 
2+   modulation. To avoid 
this complication, our CSQ2-free RyR2 channels were ac-
tivated by 100   μ  M cytosolic Ca 
2+   only to assure the cyto-
solic Ca 
2+   activation site was saturated. 
  In these conditions, CSQ2-free RyR2 channels were 
sensitive to luminal Ca 
2+   concentrations. The Po of CSQ2-
free channels doubled (    0.4 to     0.8) when luminal 
Ca 
2+   was raised from 10   μ  M to 10 mM. The same thing 
happened if luminal Mg 
2+  , instead of luminal Ca 
2+  , was 
applied. Thus, a CSQ2-independent form of luminal 
RyR2 Ca 
2+   regulation exists and it does not distinguish 
between luminal Ca 
2+   and Mg 
2+  . To our knowledge, the 
ion selectivity of luminal Ca 
2+   control mechanisms has 
rarely (if ever) been tested before. 
  The lack of Ca 
2+   specifi  city makes the physiological rel-
evance of this CSQ2-independent regulation arguable. 
This regulatory pathway could conceivably become im-
portant in certain pathological conditions. For example, 
cardiac SR overload could conceivably raise the total in-
tra-SR divalent concentration suffi  ciently to be sensed by 
this mechanism. If so, then our results suggest this mech-
anism would modulate cytosolic Ca 
2+   activation effi  cacy 
(not its affi  nity). Effi  cacy here refers to the maximum Po 
attainable by cytosolic Ca 
2+   stimulation (affi  nity to the 
cytosolic Ca 
2+   EC  50  ). Intra-SR divalent overload would 
then increase the maximal Po attainable by a cytosolic 
Ca 
2+   stimulus, explaining the excess RyR2-mediated Ca 
2+   
release associated with this pathological condition. Alter-
natively, this mechanism may just assure that RyR2 chan-
nels respond robustly to cytosolic Ca 
2+   stimuli. 
  Luminal RyR2 Ca 
2+   Regulation with CSQ2 Present 
  We showed that CSQ2-associated RyR2 channels, acti-
vated by 1  μ  M cytosolic Ca 
2+  , were sensitive to luminal Ca 
2+  . 
They were not sensitive to changes in luminal Mg 
2+  . 
Thus, the CSQ2-dependent luminal RyR2 Ca 
2+   regula-
tion mechanism distinguishes between these ions. It does 
not require the presence of another cytosolic activator 
(ATP or sulmazole). It does not require the presence of 
additional free CSQ2 in the luminal bath as illustrated 
by   Fig. 1 B   (fi  lled circles) where regulation occurs with 
Triadin (  Marty, 2004  ) that runs on SDS gels as an     40-
kD doublet comprised of glycosylated and unglycosyl-
ated molecules. The glycosylation site of triadin is at 
asparagine residue 75 (  Kobayashi et al., 2000  ). The rela-
tive proportions of glycosylated and unglycosylated tria-
din in cardiac muscle cells varies among mammalian 
species. In human and rabbit, both are present but there 
is proportionally more unglycosylated triadin. The func-
tional signifi  cance of this is not yet clear. 
  CSQ2 binding to these two forms of cardiac triadin 
was measured.   Fig. 6   Bi shows an example triadin-CSQ2-
WT immune pull-down. The top panel shows the Coomassie 
blue  –  stained SDS-PAGE of CSQ2-WT. The bottom panel 
shows the classical triadin doublet revealed by Western 
blot with anti-triadin antibodies. Data like these were 
used to evaluate the Ca 
2+   sensitivity of glycosylated 
(fi  lled bars) and unglycosylated (open bars) cardiac tri-
adin binding to either the WT, R33Q, or L167H CSQ2 
proteins. In   Fig. 6   Bii, CSQ2  –  triadin binding was mea-
sured in the virtual absence of Ca 
2+   (EGTA) and in the 
presence of 1 mM Ca 
2+  . In vitro binding was normalized 
to that in the EGTA WT condition. There was no signifi  -
cant Ca 
2+   sensitivity of glycosylated triadin binding to 
any of the CSQ2 proteins tested. There was also no sig-
nifi  cant Ca 
2+   sensitivity of unglycosylated triadin bind-
ing to the CSQ2-L167H protein. However, binding of 
unglycosylated triadin to the CSQ2-WT protein was sig-
nifi  cantly reduced (P   <   0.05) in the presence of 1 mM 
Ca 
2+  . The binding of unglycosylated triadin to the CSQ2-
R33Q protein was nearly signifi  cant (P   >   0.06) in the 
presence of 1 mM Ca 
2+  . 
  DISCUSSION  
  Several studies of luminal Ca 
2+   regulation of single RyR1 
and RyR2 channels have been done, yielding variable 
and sometimes confusing results ( Sitsapesan and Williams, 
1995  ;   Lukyanenko et al., 1996  ;   Tripathy and Meissner, 
1996  ;   Gyorke and Gyorke, 1998  ;   Xu and Meissner, 1998  ; 
  Ching et al., 2000  ;   Beard et al., 2002  ;   Laver et al., 2004  ; 
  Beard et al., 2005  ). For example,   Sitsapesan and Williams 
(1995)   concluded that regulation of RyR2 channels by 
luminal Ca 
2+   depends on how channels are activated 
(they used sulmazole) and that channels solely activated 
by micromolar cytosolic Ca 
2+   were not sensitive to luminal 
Ca 
2+   changes.   Xu and Meissner (1998)   demonstrated 
luminal Ca 
2+   feeding through caffeine-activated chan-
nels can modulate RyR2 activity, implying that a lumi-
nally localized regulatory process may not exist. More 
recently,   Gyorke et al. (2004)   argues that luminal Ca 
2+   
feed-through is not signifi  cant but that the CSQ2  –  triadin 
complex somehow acts as a luminal Ca 
2+   regulatory sen-
sor. This is consistent with recent studies exploring the 
molecular defects underlying CPVT, which suggest that 
a CSQ2 regulatory mechanism exists (  Terentyev et al., 
2006  ). Indeed, the commonly accepted view is that there 332   Luminal Ca 
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is probably due to the methodological differences. 
In any event, there seems to be little (or no) correlation 
between CSQ2 Ca 
2+   binding properties and the CSQ2-
dependent regulation measured here. 
    Terentyev et al. (2007)   recently showed that a decoy 
peptide corresponding to the CSQ2 binding domain 
of triadin interferes with CSQ2  ’  s capacity to regulate 
single RyR2 channels. Thus, we elected to explore the 
possible role of triadin in CSQ2-dependent RyR2 reg-
ulation. We compared the Ca 
2+   sensitivity of the triadin 
interaction with WT, R33Q, and L167H. These CSQ2s 
all bind to triadin but only the binding of WT and R33Q 
with unglycosylated triadin was Ca 
2+   sensitive. Thus, the 
Ca 
2+   sensitivity of the triadin  –  CSQ2 interaction, not 
triadin  –  CSQ2 binding per se, could explain the lumi-
nal RyR2 Ca 
2+   regulation observed here. If so, then 
L167H may have bound to the triadin  –  RyR2 complex 
but did not regulate because the triadin –  CSQ2 (L167H) 
interaction is not Ca 
2+   sensitive. Whereas with R33Q 
bound, regulation would be abnormal because the 
Ca 
2+   sensitivity of the triadin  –  CSQ2 (R33Q) interaction 
is abnormal. 
    Fig. 7   illustrates our overall working interpretation.   
In this cartoon, Ca 
2+   binding to the CSQ2 monomer and 
Ca 
2+  -dependent CSQ2 oligomerization do not regulate 
the RyR2 channel. A CSQ2 monomer bound to the tria-
din  –  RyR2 complex is the key regulating entity. The Ca 
2+   
sensitivity of CSQ2  –  triadin interaction is the key lume-
nal Ca 
2+   sensing step and it discriminates between Ca 
2+   
and Mg 
2+  . Lumenal Ca 
2+   alters the cytosolic Ca 
2+   sensitiv-
ity of the channel through the RyR2  –  triadin  –  CSQ2 inter-
action. There is also a RyR2-resident, CSQ2-independent, 
lumenal Ca 
2+   regulatory pathway that does not discrimi-
nate between Ca 
2+   and Mg 
2+  . 
no unbound CSQ2 in the lumenal bath. This means 
CSQ2-dependent regulation does not involve CSQ2 as-
sociation/dissociation and that made it impractical to 
defi  ne the CSQ2 dose dependency. We considered ex-
amining the dose dependency of CSQ2 reassociation 
over a set interval but the physiological importance of 
this parameter is not entirely clear. Instead, we simply 
elected to defi  ne function at a set bath CSQ2 concentra-
tion, a concentration like that used successfully by other 
groups (  Gyorke et al., 2004  ; Beard et al., 2005    ). 
  Our results also suggest that the CSQ2-dependent 
mechanism alters the cytosolic Ca 
2+   sensitivity of the chan-
nel. At a constant luminal Ca 
2+   (1 mM), CSQ2-free and 
CSQ2-assocaited channels had different cytosolic Ca 
2+   
activation affi  nity and effi  cacy (  Fig. 4 A  , diamonds vs. 
circles). Comparing this and the data presented in   Fig. 
2 B   (circles; where 1   μ  M cytosolic Ca 
2+   is always present) 
suggests that luminal Ca 
2+   alters Po by changing the cy-
tosolic Ca 
2+   sensitivity of CSQ2-associated channels. If so, 
then our data indicates that a local luminal Ca 
2+   reduc-
tion (1 mM to 100   μ  M), in the presence of a constant 
cytosolic Ca 
2+   stimulus (1  μ  M), would turn off the channel. 
This is consistent with the work of   Gyorke and Gyorke 
(1998),   who suggested that a change in luminal Ca 
2+   
(20   μ  M to 5 mM) seemed to make ATP-activated RyR2 
channels more sensitive to cytosolic Ca 
2+   activation. 
  The CSQ2-dependent luminal Ca 
2+   regulatory mech-
anism also depended on CSQ2 structure  –  function. Two 
different CSQ2 mutants (R33Q and L167H) were tested 
here. The L167H CSQ2 mutant did not support CSQ2-
dependent regulation. The R33Q mutant did but ab-
normally. The Po of WT and R33Q-associated channels 
at 1 mM was similar. However, channels associated with 
R33Q were not   “  turned off  ”   as effectively when luminal 
Ca 
2+   was reduced   <  1 mM (compared with channels as-
sociated with WT CSQ2). This is quite consistent with 
the observations reported in   Terentyev et al. (2006)  . 
  How are changes to luminal Ca 
2+   sensed by the CSQ2  –
  RyR2 complex? This could involve Ca 
2+  -dependent CSQ2 
polymerization, Ca 
2+   binding to the CSQ2 monomer, 
and/or some sort of Ca 
2+  -dependent CSQ2  –  RyR2 inter-
action. Calcium-dependent CSQ2 polymerization does 
not seem to play a part because the observed regulation 
does involve CSQ2 association/dissociation (see discus-
sion above). There also seems to be little (or no) corre-
lation between CSQ2 Ca 
2+   binding properties and the 
observed CSQ2-dependent RyR2 luminal Ca 
2+   regula-
tion. This latter point is based on the known Ca 
2+   bind-
ing properties of the CSQ2s tested here (WT, R33Q, 
and L167H).   di Barletta et al. (2006)   reported that the 
Ca 
2+   affi  nities and B  MAX  s of these CSQ2s were not statis-
tically different (  t   test P   >   0.45).   Kim et al. (2007)   re-
ported that the Ca 
2+   binding capacity of the L167H 
monomer is     50% less (compared with WT) and that 
R33Q had reduced Ca 
2+   binding capacity at high Ca 
2+   
levels. This apparent discrepancy between these studies 
  Figure 7.     Summary cartoon of RyR2 luminal Ca 
2+   regulation. 
Triadin is labeled TR. Calcium binding sites that activate channel 
are indicated with a plus. The cytosolic Ca 
2+   inhibitory site is marked 
with a minus. Proteins are not drawn to scale.         Qin et al.  333
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  The Cellular Context 
  The intra-SR free Ca 
2+   concentration in a resting car-
diac myocyte is likely close to 1 mM (  Bers, 2004  ). In re-
sponse to a single cardiac action potential, the intra-SR 
free Ca 
2+   concentration may fall to     50% of its normal 
resting value (  Shannon et al., 2000  ). High frequency 
stimulation or larger SR Ca 
2+   releases may drive intra-SR 
Ca 
2+   levels to even lower levels. Our results suggest that 
such changes in luminal Ca 
2+   inhibit the channel by 
reducing its cytosolic Ca 
2+   sensitivity and thus help ter-
minate the SR Ca 
2+   release process. As intra-SR Ca 
2+   lev-
els are replenished, the cytosolic Ca 
2+   sensitivity of the 
channel would return to its resting condition. 
    di Barletta et al. (2006)   showed that overexpression 
of CSQ2-WT, not CSQ2-L167H, increased the amp-
litude of intracellular Ca 
2+   sparks/transients. In that 
study, the new CSQ2 was expressed on top of the nor-
mal complement of CSQ2-WT. Our observation that 
L167H has no RyR2 regulatory action is then quite con-
sistent with   di Barletta et al. (2006)  . Our R33Q results 
are also consistent because they show R33Q was sub-
stantially less effective in turning off R33Q-assocaited 
channels. Thus, cells containing R33Q should have 
RyR2 channels with a greater propensity to open during 
diastole, promoting increased SR Ca 
2+   leak and frequency 
of spontaneous SR Ca 
2+   release events (as observed by 
  Terentyev et al., 2006  ). 
  Our results show that two CPVT-linked CSQ2 mutants 
have very different actions on single RyR2 luminal Ca 
2+   
regulation. Since several RyR2 channel mutations also 
generate CPVT phenotypes (with WT CSQ2 present), 
it is becoming clear that CVPT can result from any of a 
number of defects that modify or abolish normal RyR2 
luminal Ca 
2+   regulation. Although no triadin-linked 
forms of CPVT have been identifi  ed yet, it would not be 
surprising if one was in the near future. Lastly, our stud-
ies of CSQ2-dependent RyR2 regulation were done un-
der stationary experimental conditions in bilayers. This 
must be considered when extrapolating our data to 
the cellular situation. In cells, CSQ2-dependent RyR2 
regulation operates in a dynamic complex regulatory 
environment that is simply not present in our studies. 
Defi  ning the kinetics of CSQ2 modulation of RyR2 
function in a more physiological context will likely be 
an important, albeit challenging, focus of future studies 
that could change our view of how CSQ2 regulates the 
RyR2 channel. 
  We would like to thank Yiwei Liu for his experimental and techni-
cal assistance. 
  This work was supported by a National Institutes of Health 
grant to M. Fill (R01HL5783) and a Telethon grant to P. Volpe 
and S.G. Priori (GGP04066). 
  Olaf S. Andersen   served as editor.
Submitted:   16 October 2007 
Accepted:   21 February 2008 334   Luminal Ca 
2+   Regulation 
      Shannon  ,   T.R. ,   K.S.     Ginsburg  , and   D.M.     Bers  .   2000  .   Potentiation 
of fractional sarcoplasmic reticulum calcium release by total and 
free intra-sarcoplasmic reticulum calcium concentration.       Biophys. J.     
  78  :  334    –    343  .   
      Sitsapesan  ,   R.  , and   A.J.     Williams  .   1995  .   The gating of the sheep skel-
etal sarcoplasmic reticulum Ca 
2+  -release channel is regulated by 
luminal Ca 
2+  .       J. Membr. Biol.       146  :  133    –    144  .   
      Slupsky  ,   J.R.  ,   M.     Ohnishi  ,   M.R.     Carpenter  , and   R.A.     Reithmeier  . 
  1987  .   Characterization of cardiac calsequestrin.       Biochemistry      .   
  26  :  6539    –    6544  .    
      Terentyev  ,   D.  ,   S.     Viatchenko-Karpinski  ,   H.H.     Valdivia  ,   A.L.     Escobar  , 
and   S.     Gyorke  .   2002  .   Luminal Ca 
2+   controls termination and re-
fractory behavior of Ca 
2+  -induced Ca 
2+   release in cardiac myocytes.   
    Circ. Res.       91  :  414    –    420  .    
      Terentyev  ,   D.  ,   A.     Nori  ,   M.     Santoro  ,   S.     Viatchenko-Karpinski  ,   Z.   
  Kubalova  ,   I.     Gyorke  ,   R.     Terentyeva  ,   S.     Vedamoorthyrao  ,   N.A.     Blom  , 
  G.     Valle  ,   et al  .   2006  .   Abnormal interactions of calsequestrin with 
the ryanodine receptor calcium release channel complex linked to 
exercise-induced sudden cardiac death.       Circ. Res.       98  :  1151    –    1158  .    
      Terentyev  ,   D.  ,   S.     Viatchenko-Karpinski  ,   S.     Vedamoorthyrao  ,   S.   
  Oduru  ,   I.     Gyorke  ,   S.C.     Williams  , and   S.     Gyorke  .   2007  .   Protein 
protein interactions between triadin and calsequestrin are in-
volved in modulation of sarcoplasmic reticulum calcium release 
in cardiac myocytes.       J. Physiol.       583  :  71    –    80  .    
      Treves  ,   S.  ,   B.     Vilsen  ,   P.    Chiozzi  ,   J.P.     Andersen  , and   F.    Zorzato  .   1992  . 
  Molecular cloning, functional expression and tissue distribution of 
the cDNA encoding frog skeletal muscle calsequestrin.       Biochem. J.
       283  (  Pt 3  ):  767    –    772  .   
      Tripathy  ,   A.  , and   G.     Meissner  .   1996  .   Sarcoplasmic reticulum luminal 
Ca 
2+   has access to cytosolic activation and inactivation sites of skel-
etal muscle Ca 
2+   release channel.       Biophys. J.       70  :  2600    –    2615  .   
      Tu ,   Q.  ,   P.    Velez  ,   M.     Cortes-Gutierrez  , and   M.     Fill  .   1994  .   Surface 
charge potentiates conduction through the cardiac ryanodine 
receptor channel.       J. Gen. Physiol.       103  :  853    –    867  .    
      Xu  ,   L.  , and   G.     Meissner  .   1998  .   Regulation of cardiac muscle Ca 
2+   
release channel by sarcoplasmic reticulum luminal Ca 
2+  .       Biophys. 
J.       75  :  2302    –    2312  .   
      Xu  ,   L.  ,   Y.    Wang  ,   D.     Gillespie  , and   G.     Meissner  .   2006  .   Two rings of 
negative charges in the cytosolic vestibule of type-1 ryanodine re-
ceptor modulate ion fl  uxes.       Biophys. J.       90  :  443    –    453  .    
      Yano  ,   K.  , and   A.     Zarain-Herzberg  .   1994  .   Sarcoplasmic reticulum 
calsequestrins: structural and functional properties.       Mol. Cell. 
Biochem.       135  :  61    –    70  .                      
      Laver  ,   D.R.  ,   E.R.     O  ’  Neill  , and   G.D.     Lamb  .   2004  .   Luminal Ca 
2+  -regu-
lated Mg 
2+   inhibition of skeletal RyRs reconstituted as isolated 
channels or coupled clusters.       J. Gen. Physiol.       124  :  741    –    758  .    
      Leenhardt  ,   A.  ,   V.    Lucet  ,   I.     Denjoy  ,   F.    Grau  ,   D.D.     Ngoc  , and   P.    Coumel  . 
  1995  .  Catecholaminergic polymorphic ventricular tachycardia in chil-
dren. A 7-year follow-up of 21 patients.       Circulation      .     91  :  1512    –    1519  .   
      Lowry  ,   O.H.  ,   N.J.     Rosebrough  ,   A.L.     Farr  , and   R.J.     Randall  .   1951  . 
  Protein measurement with the Folin phenol reagent.       J. Biol. 
Chem.       193  :  265    –    275  .   
      Lukyanenko  ,   V. ,   I.     Gyorke  , and   S.     Gyorke  .   1996  .   Regulation of cal-
cium release by calcium inside the sarcoplasmic reticulum in ven-
tricular myocytes.       Pfl  ugers Arch.       432  :  1047    –    1054  .    
      Lukyanenko  ,   V. ,   S.     Viatchenko-Karpinski  ,   A.     Smirnov  ,   T.F.    Wiesner  , 
and   S.     Gyorke  .   2001  .   Dynamic regulation of sarcoplasmic reticu-
lum Ca 
2+   content and release by luminal Ca 
2+  -sensitive leak in rat 
ventricular myocytes.       Biophys. J.       81  :  785    –    798  .   
      Marty  ,   I.     2004  .   Triadin: a multi-protein family for which purpose?   
    Cell. Mol. Life Sci.       61  :  1850    –    1853  .   
      Mejia-Alvarez  ,  R.  ,  C.    Kettlun  ,  E.    Rios  ,  M.    Stern  , and  M.    Fill  .  1999  .  Unitary 
Ca 
2+   current through cardiac ryanodine receptor channels under 
quasi-physiological ionic conditions.       J. Gen. Physiol.       113  :  177    –    186  .    
      Mitchell  ,   R.D.  ,   H.K.     Simmerman  , and   L.R.     Jones  .   1988  .   Ca 
2+   bind-
ing effects on protein conformation and protein interactions of 
canine cardiac calsequestrin.       J. Biol. Chem.       263  :  1376    –    1381  .   
      Paolini  ,   C.  ,   M.     Quarta  ,   A.     Nori  ,   S.     Boncompagni  ,   M.     Canato  ,   P.  
  Volpe  ,   P.D.    Allen  ,   C.     Reggiani  , and   F.    Protasi  .   2007  .   Reorganized 
stores and impaired calcium handling in skeletal muscle of mice 
lacking calsequestrin-1.       J. Physiol.       583  :  767    –    784  .    
      Park  ,   H.  ,   S.     Wu  ,   A.K.     Dunker  , and   C.     Kang  .   2003  .   Polymerization 
of calsequestrin. Implications for Ca 
2+   regulation.       J. Biol. Chem.     
  278  :  16176    –    16182  .    
      di Barletta  ,   M.R.  ,   S.     Viatchenko-Karpinski  ,   A.     Nori  ,   M.     Memmi  ,   D.   
  Terentyev  ,   F.    Turcato  ,   G.     Valle  ,   N.     Rizzi  ,   C.     Napolitano  ,   S.     Gyorke  , 
  et al  .   2006  .   Clinical phenotype and functional characterization 
of CASQ2 mutations associated with catecholaminergic polymor-
phic ventricular tachycardia.       Circulation      .     114  :  1012    –    1019  .    
      Saito  ,   A.  ,   S.     Seiler  ,   A.     Chu  , and   S.     Fleischer  .   1984  .   Preparation and 
morphology of sarcoplasmic reticulum terminal cisternae from 
rabbit skeletal muscle.       J. Cell Biol.       99  :  875    –    885  .    
      Scott  ,   B.T.  ,   H.K.     Simmerman  ,   J.H.     Collins  ,   B.     Nadal-Ginard  , and 
  L.R.     Jones  .   1988  .   Complete amino acid sequence of canine 
cardiac calsequestrin deduced by cDNA cloning.       J. Biol. Chem.     
  263  :  8958    –    8964  .   